Louisa Müller‐Miny

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 184 citations · Full text

Veterinary Medicine, Internal Medicine, Pharmacotherapy +3

Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks

Priya S. Kishnani, Jordi Díaz‐Manera, António Toscano et al. · JAMA Neurology · 2023 · 55 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +8

Supporting the differential diagnosis of connective tissue diseases with neurological involvement by blood and cerebrospinal fluid flow cytometry

Michael Heming, Louisa Müller‐Miny, Leoni Rolfes et al. · Journal of Neuroinflammation · 2023 · 14 citations · Full text

Life Sciences, Clinical Sciences, Neurology +17

Activated αβ T and reduced mucosa-associated invariant T cells in LGI1- and CASPR2-encephalitis

Daniela Esser, Louisa Müller‐Miny, Michael Heming et al. · Brain · 2025 · 14 citations · Full text

Life Sciences, Immunology, Neurology +17

Association of polysialic acid serum levels with schizophrenia spectrum and bipolar disorder-related structural brain changes and hospitalization

Louisa Müller‐Miny, Katharina Thiel, Susanne Meinert et al. · Scientific Reports · 2023 · 13 citations · Full text

Life Sciences, Neuroscience, Psychiatry +15